Zorecimeran - CISMeF

Preferred Label : Zorecimeran;

NCIt synonyms : CVnCoV; COVID-19 mRNA Vaccine CVnCoV; CVnCoV Vaccine; LNP-encapsulated SARS-CoV-2 mRNA Vaccine CVnCoV;

NCIt definition : A vaccine consisting of a lipid nanoparticle (LNP) encapsulating a messenger RNA (mRNA) encoding the full-length spike (S) protein of severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), with potential immunizing activity against SARS-CoV-2. Upon intramuscular administration of zorecimeran, the LNP binds to the plasma membrane of cells and releases the mRNA into the cells. The mRNA is then translated by ribosomes to produce the SARS-CoV-2 S protein. This may activate both humoral and cellular immune responses which may result in protection against SARS-CoV-2 infection. S-protein, usually found on the surface of SARS-CoV-2, plays an essential role in the infection pathway of the SARS-CoV-2 virus.;

UNII : 5TP24STD1S;

CAS number : 2432957-15-6;

Molecule name : CV-07050101; CV 07050101;

NCI Metathesaurus CUI : CL1407645;

Details

Origin ID

C173851;

UMLS CUI

C5446356;

Automatic exact mappings (from CISMeF team)
- CVnCoV Vaccine [COVID-19 Thesaurus concept]
Currated CISMeF NLP mapping
- Zorecimeran [SMS substance]
Semantic type(s)
- Immunologic Factor [UMLS semantic type]
- Nucleic Acid, Nucleoside, or Nucleotide [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (medicinal product) [SNOMED CT concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
- NCIt COVID-19 Agent Terminology [NCIt concept]
- NCIt COVID-19 Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients